Physician profile
Janet Haymore
NPI 1396141636
$1,425.96
in general payments reported to CMS, 2019-2025
20 companies · $535 in 2025
The $535 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.85 · 2023: $201 · 2024: $669 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,404.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $473.07 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $178.85 | 2024-2025 | Caplyta |
| Glaxosmithkline, LLC. | $110.57 | 2024-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Dexcom, INC. | $88.82 | 2024-2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $88.39 | 2024-2025 | Gemtesa |
| Abbvie INC. | $85.68 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $82.21 | 2023-2024 | Farxiga |
| Xeris Pharmaceuticals, INC. | $50.23 | 2023-2025 | Gvoke Hypopen |
| Amgen INC. | $30.41 | 2024-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $30.31 | 2023-2024 | |
| Inspire Medical Systems, INC. | $30.18 | 2024 | Inspire |
| Alkermes, INC. | $23.74 | 2023 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $23.29 | 2023 | Rexulti |
| Sun Pharmaceutical Industries INC. | $21.85 | 2021 | |
| Pfizer INC. | $20.98 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $20.15 | 2024 | (Ck7) Extended Holter |
| Astellas Pharma US INC | $19.71 | 2024 | Veozah |
| Lilly USA, LLC | $16.48 | 2023 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.81 | 2023 | Jardiance |
| Exact Sciences Corporation | $15.23 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Haymore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.